As of October 2024, VitaSpring Biomedical has a market cap of $3.30B. This makes VitaSpring Biomedical the world's 3735th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.30B | 0.00% |
2023 | $3.30B | 11.11% |
2022 | $2.97B | -26.15% |
2021 | $4.03B | 62.50% |
2020 | $2.48B | 2757.14% |
2019 | $86.74M | - |